Adherence to medications by patients after acute coronary syndromes

被引:75
作者
Sud, A
Kline-Rogers, EM
Eagle, KA
Fang, JM
Armstrong, DF
Rangarajan, K
Otten, RF
Stafkey-Mailey, DR
Taylor, SD
Erickson, SR
机构
[1] Univ Michigan, Coll Pharm, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Coll Med, Ann Arbor, MI 48109 USA
关键词
acute coronary syndrome; adherence;
D O I
10.1345/aph.1G249
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: Nonadherence to medication may lead to poor medical outcomes. OBJECTIVE: To describe medication-taking behavior of patients with a history of acute coronary syndromes (ACS) for 4 classes of drugs and determine the relationship between self-reported adherence and patient characteristics. METHODS: Consenting patients with the diagnosis of ACS were interviewed by telephone approximately 10 months after discharge. The survey elicited data characterizing the patient, current medication regimens, beliefs about drug therapy, reasons for discontinuing medications, and adherence. The survey included the Beliefs About Medicine Questionnaire providing 4 scales: Specific Necessity, Specific Concerns, General Harm, and General Overuse, and the Medication Adherence Scale (MAS). Multivariate regression was used to determine the independent variables with the strongest association to the MAS. A p value <= 0.05 was considered significant for all analyses. RESULTS: Two hundred eight patients were interviewed. Mean +/- SD age was 64.9 +/- 13.0 years, with 60.6% male, 95.7% white, 57.3% with a college education, 87.9% living with 1 other person, and 42% indicating excellent or very good health. The percentage of patients continuing on medication at the time of the survey category ranged from 87.4% (aspirin) to 66.0% (angiotensin-converting enzyme inhibitors). Reasons for stopping medication included physician discontinuation or adverse effects. Of patients still on drug therapy, the mean MAS was 1.3 +/- 0.4, with 53.8% indicating nonadherence (score > 1). The final regression model showed R-2 = 0.132 and included heart-related health status and Specific Necessity as significant predictor variables. CONCLUSIONS: After ACS, not all patients continue their drugs or take them exactly as prescribed. Determining beliefs about illness and medication may be helpful in developing interventions aimed at improving adherence.
引用
收藏
页码:1792 / 1797
页数:6
相关论文
共 50 条
  • [1] Patients' adherence to secondary prevention pharmacotherapy after acute coronary syndromes
    Kassab, Yaman
    Hassan, Yahaya
    Abd Aziz, Noorizan
    Ismail, Omar
    AbdulRazzaq, Hadeer
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (02) : 275 - 280
  • [2] Patients’ adherence to secondary prevention pharmacotherapy after acute coronary syndromes
    Yaman Kassab
    Yahaya Hassan
    Noorizan Abd Aziz
    Omar Ismail
    Hadeer AbdulRazzaq
    International Journal of Clinical Pharmacy, 2013, 35 : 275 - 280
  • [3] Predictors of adherence to composite therapy after acute coronary syndromes
    Stabile, Eugenio
    Franzese, Michele
    Chianese, Salvatore
    Alfani, Arturo
    Gerardi, Donato
    Colaiori, Iginio
    Annunziata, Monica
    Nappi, Pierluigi
    Scalise, Martina
    Di Serafino, Luigi
    Puzone, Brunella
    Avvedimento, Marisa
    Leone, Attilio
    Ilardi, Federica
    Piccolo, Raffaele
    Franzone, Anna
    Cirillo, Plinio
    Morisco, Carmine
    Trimarco, Bruno
    Esposito, Giovanni
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2021, 22 (08) : 645 - 651
  • [4] Trends in adherence to secondary prevention medications in post-acute coronary syndrome patients
    Kassab, Yaman Walid
    Hassan, Yahaya
    Abd Aziz, Noorizan
    Zulkifly, Hanis Hanum
    Iqbal, Muhammad Shahid
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 28 (02) : 641 - 646
  • [5] Factors associated with clopidogrel use, adherence, and persistence in patients with acute coronary syndromes undergoing percutaneous coronary intervention
    Zhu, Baojin
    Zhao, Zhenxiang
    McCollam, Patrick
    Anderson, Johnna
    Bae, Jay P.
    Fu, Haoda
    Zettler, Marjie
    LeNarz, LeRoy
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (03) : 633 - 641
  • [6] Prognosis of Patients With Familial Hypercholesterolemia After Acute Coronary Syndromes
    Nanchen, David
    Gencer, Baris
    Muller, Olivier
    Auer, Reto
    Aghlmandi, Soheila
    Heg, Dik
    Klingenberg, Roland
    Raber, Lorenz
    Carballo, David
    Carballo, Sebastian
    Matter, Christian M.
    Luscher, Thomas F.
    Windecker, Stephan
    Mach, Francois
    Rodondi, Nicolas
    CIRCULATION, 2016, 134 (10) : 698 - 709
  • [7] Antiplatelet medications in acute coronary syndromes and percutaneous coronary interventions: focus on tirofiban
    Batyraliev, T. A.
    Preobrazhensky, D., V
    Fetzer, D., V
    Sidorenko, B. A.
    Pataraya, S. A.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2008, 7 (06): : 79 - 88
  • [8] Influence of Psychological Factors on Treatment Adherence in Acute Coronary Syndromes
    Oprescu, N.
    Micheu, M. M.
    Scarlatescu, A.
    Udrea, O. M.
    Dorobantu, M.
    NEW APPROACHES IN SOCIAL AND HUMANISTIC SCIENCES, 2016, : 361 - 367
  • [9] Adherence to Cardio-protective Medications Prescribed for Secondary Prevention After Hospitalization for an Acute Coronary Syndrome
    Rana, Jamal S.
    Parker, Melissa M.
    Moffet, Howard H.
    Karter, Andrew J.
    CIRCULATION, 2017, 136
  • [10] Anxiety in patients with acute coronary syndromes
    Ciric-Zdravkovic, Snezana V.
    Zikic, Olivera V.
    Stanojevic, Dragana M.
    Petrovic-Nagorni, Svetlana M.
    EUROPEAN JOURNAL OF PSYCHIATRY, 2014, 28 (03) : 165 - 171